Unilever Goes To Multi-Omics Data With Goal Of Personalizing Acne Intervention
Executive Summary
Unilever aims to use Onegevity’s AI and multi-omics database as a platform to develop “new diagnostic models that offer bespoke acne management regiments,” according to the New York-based health intelligence company’s announcement.
You may also be interested in...
Unilever Divests Dollar Shave Club, Focused On 30 ‘Power Brands’ Under New CEO’s Action Plan
More brands, particularly those acquired prior to Unilever’s 2019 shift in M&A strategy, could be on the chopping block, according to CEO Hein Schumacher, who took the helm in July. His targeted action plan includes investments to accelerate innovation and increase brand and marketing support.
Unilever Says Findings On Microbiome-Boosting Lipid Technology Will Fuel Product Innovation
Unilever’s research partnerships are paying off, yielding microbiome findings that are accelerating the firm’s innovation pipeline, with new products envisioned for treating scalp, underarms and oral health in addition to skin, the firm says.
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.